18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma. (Q48509442)

12 February 2018

title

18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma. (English)

1 reference

12 February 2018

main subject

nanoparticle

0 references

magnetite nanoparticle

0 references

magnetic nanoparticle

1 reference

6

1 reference

12 February 2018

Matthias Gutberlet

7

object named as

Matthias Gutberlet

1 reference

12 February 2018

Michail Plotkin

1

1 reference

12 February 2018

Uwe Gneveckow

2

1 reference

12 February 2018

Klaus Meier-Hauff

3

1 reference

12 February 2018

Holger Amthauer

4

1 reference

12 February 2018

Annelie Feussner

5

1 reference

12 February 2018

Andreas Jordan

8

1 reference

12 February 2018

Roland Felix

9

1 reference

12 February 2018

Peter Wust

10

1 reference

12 February 2018

publication date

1 June 2006

1 reference

12 February 2018

International Journal of Hyperthermia

published in

1 reference

12 February 2018

volume

22

1 reference

12 February 2018

page(s)

319-325

1 reference

12 February 2018

issue

4

1 reference

12 February 2018

Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Relevance of image fusion with MRI for the interpretation of I-123 iodo-methyl-tyrosine scans in patients with suspected recurrent or residual brain tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Evaluation of Magnetic Fluid Hyperthermia in a Standard Rat Model of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

Current imaging techniques for the evaluation of brain neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730600734128

10.1080/02656730600734128

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

16754352

1 reference

12 February 2018